Stock IMNN IMUNON, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Imunon, Inc.

Equities

IMNN

US15117N6022

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
1.44 USD +10.77% Intraday chart for Imunon, Inc. +28.00% +111.76%
Apr. 18 Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine MT
Apr. 18 Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine DJ

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine
MT
Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine
DJ
IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101
AQ
Imunon, Inc. Application Cleared to Begin Human Testing of IMNN-101
CI
IMUNON Reports Compliance with Nasdaq Listing Requirements
AQ
HC Wainwright Adjust Price Target on Imunon to $13 From $12, Keeps Buy Rating
MT
Top Midday Gainers
MT
Transcript : Imunon, Inc., Q4 2023 Earnings Call, Mar 28, 2024
Imunon, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
IMUNON Reports 2023 Financial Results and Provides Business Update
AQ
North American Morning Briefing : Stocks Set for -2-
DJ
IMUNON Receives $1.3 Million from Sale of its New Jersey Net Operating Losses
AQ
IMUNON to Hold 2023 Financial Results and Business Update Conference Call on Thursday, March 28, 2024
AQ
IMUNON Files IND Application to Begin Human Testing of IMNN-101
AQ
Imunon, Inc. Files Ind Application to Begin Human Testing of Imnn-101
CI
IMUNON Names Executive Chairman as Temporary Head Following Resignation of CEO Corinne Le Goff
MT
IMUNON Announces Leadership Change
AQ
Imunon, Inc. Announces Executive Changes
CI
Imunon, Inc. Announces Resignation of Corinne Le Goff as Chief Executive Officer, Effective March 15, 2024
CI
Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMNN Stock
  4. News Imunon, Inc.